These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30582730)

  • 1. Co-existence of mycobacterial infections: is it an emerging issue with retroviral infections?
    Keragala B; Herath H; Janappriya G; Gunasekera CN
    Trop Doct; 2019 Apr; 49(2):145-146. PubMed ID: 30582730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in leprosy manifestations among HIV-positive patients, Manaus, Brazil.
    Talhari C; Matsuo C; Chrusciak-Talhari A; de-Lima-Ferreira LC; Mira M; Talhari S
    Emerg Infect Dis; 2009 Apr; 15(4):673-4. PubMed ID: 19331771
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of histoid leprosy in a HIV infected person on HAART not responding to conventional MB-MDT.
    Kolaparambath BA; Rajagopal R
    Indian J Lepr; 2014; 86(1):15-8. PubMed ID: 25163256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
    Krenzien HN
    Lepr Rev; 1975 Jun; 46(2 Suppl):189-98. PubMed ID: 1100960
    [No Abstract]   [Full Text] [Related]  

  • 5. Leprosy as immune reconstitution inflammatory syndrome in HIV-positive persons.
    Martiniuk F; Rao SD; Rea TH; Glickman MS; Giovinazzo J; Rom WN; Cabrera A; Levis WR
    Emerg Infect Dis; 2007 Sep; 13(9):1438-40. PubMed ID: 18252138
    [No Abstract]   [Full Text] [Related]  

  • 6. An unusual reaction to rifampicin in a once monthly dose.
    Sule RR
    Lepr Rev; 1996 Sep; 67(3):227-8. PubMed ID: 8885617
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of tuberculosis and leprosy.
    Ellard GA
    Lepr Rev; 1975 Sep; 46(3):149-55. PubMed ID: 1102829
    [No Abstract]   [Full Text] [Related]  

  • 8. Do complications occur under multi-drug therapy?
    Palande DD
    Indian J Lepr; 1987; 59(4):369-72. PubMed ID: 3451922
    [No Abstract]   [Full Text] [Related]  

  • 9. Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.
    Mieras L; Anthony R; van Brakel W; Bratschi MW; van den Broek J; Cambau E; Cavaliero A; Kasang C; Perera G; Reichman L; Richardus JH; Saunderson P; Steinmann P; Yew WW
    Infect Dis Poverty; 2016 Jun; 5(1):46. PubMed ID: 27268059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampicin and isoprodian in combination in the treatment of leprosy.
    Depasquale G
    Lepr Rev; 1975 Jun; 46(2 Suppl):179-80. PubMed ID: 1100958
    [No Abstract]   [Full Text] [Related]  

  • 11. A Case of Histoid Leprosy in a HIV Infected Person on HAART not responding to conventional MB MDT.
    Kolaparambath BA; Rajagopal R
    Indian J Lepr; 2014; 86(4):165-9. PubMed ID: 26411250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leprosy and HIV coinfection: a critical approach.
    Massone C; Talhari C; Ribeiro-Rodrigues R; Sindeaux RH; Mira MT; Talhari S; Naafs B
    Expert Rev Anti Infect Ther; 2011 Jun; 9(6):701-10. PubMed ID: 21692674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leprosy and HIV co-infection in five patients.
    Trindade MA; Manini MI; Masetti JH; Leite MA; Takahashi MD; Naafs B
    Lepr Rev; 2005 Jun; 76(2):162-6. PubMed ID: 16038250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of mycobacterial infections - Mycobacterium tuberculosis and Mycobacterium leprae - in Sri Lanka: a case series.
    Keragala BSDP; Herath HMMTB; Janapriya GHDC; Vanitha S; Balendran T; Janani T; Keragala TS; Gunasekera CN
    J Med Case Rep; 2020 Jul; 14(1):101. PubMed ID: 32669124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.
    Aschhoff M
    Lepr Rev; 1975 Jun; 46(2 Suppl):173-8. PubMed ID: 1165697
    [No Abstract]   [Full Text] [Related]  

  • 16. Informal consultation on rifampicin resistance in leprosy.
    Lepr Rev; 2007 Sep; 78(3):295-305. PubMed ID: 18035782
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary rifampin resistance following multi-drug therapy--a case report.
    Norman G; Joseph G; Ebenezer G; Rao SP; Job CK
    Int J Lepr Other Mycobact Dis; 2003 Mar; 71(1):18-21. PubMed ID: 12914130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leprosy and tuberculosis co-infection: clinical and immunological report of two cases and review of the literature.
    Trindade MÂ; Miyamoto D; Benard G; Sakai-Valente NY; Vasconcelos Dde M; Naafs B
    Am J Trop Med Hyg; 2013 Feb; 88(2):236-40. PubMed ID: 23208884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.
    Chum HJ
    Lepr Rev; 1986; 57 Suppl 3():63-6. PubMed ID: 3573963
    [No Abstract]   [Full Text] [Related]  

  • 20. The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
    Depasquale G
    Lepr Rev; 1986; 57 Suppl 3():29-37. PubMed ID: 3573957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.